Susquehanna International Group, LLP Kura Oncology, Inc. Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 43,859 shares of KURA stock, worth $842,531. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,859

Previous 594,879 92.63%

Holding current value

$842,531

Previous $12.7 Million 92.88%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$17.53 - $22.98 $9.66 Million - $12.7 Million	-551,020 Reduced 92.63%	43,859 $903,000
Q1 2024 May 07, 2024	BUY	$13.42 - $23.53 $7.12 Million - $12.5 Million	530,196 Added 819.68%	594,879 $12.7 Million
Q4 2023 Feb 14, 2024	SELL	$7.58 - $14.38 $202,241 - $383,672	-26,681 Reduced 29.2%	64,683 $930,000
Q3 2023 Nov 14, 2023	SELL	$8.44 - $11.86 $27,978 - $39,315	-3,315 Reduced 3.5%	91,364 $833,000
Q2 2023 Aug 11, 2023	SELL	$9.62 - $13.99 $146,858 - $213,571	-15,266 Reduced 13.89%	94,679 $1 Million
Q1 2023 May 16, 2023	BUY	$10.71 - $14.6 $523,858 - $714,129	48,913 Added 80.14%	109,945 $1.34 Million
Q4 2022 Feb 14, 2023	SELL	$11.23 - $16.9 $531,605 - $800,012	-47,338 Reduced 43.68%	61,032 $757,000
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $1.3 Million - $2.11 Million	108,370 New	108,370 $1.48 Million
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $1.4 Million - $2.01 Million	-118,432 Reduced 65.81%	61,529 $989,000
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $1.29 Million - $2.07 Million	105,886 Added 142.94%	179,961 $2.52 Million
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $523,894 - $737,937	33,975 Added 84.73%	74,075 $1.39 Million
Q2 2021 Aug 11, 2021	BUY	$20.85 - $29.88 $521,354 - $747,149	25,005 Added 165.65%	40,100 $836,000
Q1 2021 May 17, 2021	SELL	$24.75 - $39.14 $3.18 Million - $5.04 Million	-128,658 Reduced 89.5%	15,095 $427,000
Q4 2020 Feb 16, 2021	SELL	$29.0 - $41.62 $3.27 Million - $4.69 Million	-112,791 Reduced 43.97%	143,753 $4.7 Million
Q3 2020 Nov 16, 2020	BUY	$16.3 - $30.64 $3.06 Million - $5.76 Million	187,986 Added 274.2%	256,544 $7.86 Million
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $370,024 - $875,492	46,544 Added 211.43%	68,558 $1.12 Million
Q1 2020 May 15, 2020	BUY	$6.45 - $14.04 $21,394 - $46,570	3,317 Added 17.74%	22,014 $219,000
Q3 2019 Nov 14, 2019	SELL	$14.75 - $20.87 $123,295 - $174,452	-8,359 Reduced 30.9%	18,697 $284,000
Q2 2019 Aug 16, 2019	BUY	$14.71 - $19.79 $116,003 - $156,063	7,886 Added 41.14%	27,056 $533,000
Q2 2019 Aug 14, 2019	BUY	$14.71 - $19.79 $281,990 - $379,374	19,170 New	19,170 $377,000

Others Institutions Holding KURA

# of Institutions

181

Shares Held

80.2M

Call Options Held

148K

Put Options Held

63K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.29B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Kura Oncology, Inc. Transaction History